Advertisement
Saturday, Jan 29, 2022
Outlook.com
Outlook.com

Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children

The submission is based on results of Bharat Biotech's Phase 2/3 paediatric clinical trial involving 526 children between 2-18 years of age.

Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children
Representational Image | PTI
Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children
outlookindia.com
2021-11-05T22:58:33+05:30

Bharat Biotech's partner for USA and Canada for Covid-19 vaccine Covaxin, Ocugen Inc., on Friday submitted a request to the U.S. Food and Drug Administration (FDA) seeking  Emergency Use Authorization (EUA) status of the jab for paediatric use.

According to  Ocugen, the submission is based on results of Bharat Biotech's Phase 2/3 paediatric clinical trial  involving 526 children between 2-18 years of age, which bridged immunogenicity data to a large, Phase 3 safety and efficacy clinical trial in nearly 25,800 adults in India,

"Filing for Emergency Use Authorization in the U.S. for paediatric use is a significant step toward our hope to make our vaccine candidate available here and help combat the Covid-19 pandemic,” Shankar Musunuri, Chairman of the Board, Chief Executive Officer and Co-Founder of Ocugen said.

Some research suggests that people are seeking more choices when selecting a vaccine, especially for their children. Having a new type of vaccine available will enable people to discuss with their child’s physician the best approach for them to lower their child’s risk of contracting Covid-19, he further said.

"The inactivated virus platform has been used for decades in vaccines for the paediatric population and, if authorized, we hope to offer another vaccine option to protect children as young as two years," he added.

A Phase 2/3, open-label, multi-center study was conducted in India from May 2021 to July 2021 to evaluate the safety, reactogenicity and immunogenicity of the whole-virion inactivated Vaccine in healthy volunteers in the 2-18 age group.

Covaxin was evaluated in three age groups: 2-6 years, 6-12 years and 12-18 years. All participants received two doses of the vaccine 28 days apart, it said.
Covaxin was recently awarded Emergency Use Listing by the World Health Organization. 

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement